INCYIncyte
Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. 10-K, Item 1
- Employees
- 2,844
- Headquarters
- Wilmington, DE
- CEO
- William Meury
- Next results
- around Feb 9, 2027
From 2021 to 2025, CEO pay as reported rose 166% while net income rose 36%. $100 in the shares at the start of the table was worth $114 at the end (peer group: $120). CEO pay over the 5 years: $103.7M.
| Fiscal year to | CEO | CEO pay (reported) | CEO pay (actually paid) | Other executives, average | $100 became | Peer group | Net income | Total product revenues |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Mr. Meury | $38.5M | $78.1M | $6.3M | $114 | $120 | $1.3B | $4.4B |
| Dec 31, 2024 | Mr. Hoppenot | $17.5M | $25.2M | $5.9M | $79 | $91 | $32.6M | $3.6B |
| Dec 31, 2023 | Mr. Hoppenot | $16.7M | $7.8M | $7.8M | $72 | $92 | $597.6M | $3.2B |
| Dec 31, 2022 | Mr. Hoppenot | $16.7M | $16.0M | $5.8M | $92 | $89 | $340.7M | $2.7B |
| Dec 31, 2021 | Mr. Hoppenot | $14.4M | $6.2M | $5.2M | $84 | $99 | $948.6M | $2.3B |
Pay versus performance table of the proxy statement (DEF 14A) filed Apr 28, 2026, as tagged by the company in XBRL. Open the proxy ↗
Work on INCY in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/INCY/export.csv") into a cell.